HERON THERAPEUTICS, INC. /DE/ Quarterly Operating Lease, Payments in USD from Q1 2019 to Q3 2020

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Heron Therapeutics, Inc. /De/ annual/quarterly Operating Lease, Payments history and growth rate from Q1 2019 to Q3 2020.
  • Heron Therapeutics, Inc. /De/ Operating Lease, Payments for the quarter ending September 30, 2020 was $1M, a 25% increase year-over-year.
  • Heron Therapeutics, Inc. /De/ Operating Lease, Payments for the twelve months ending September 30, 2020 was $3.3M.
  • Heron Therapeutics, Inc. /De/ annual Operating Lease, Payments for 2023 was $3M, a 3.45% increase from 2022.
  • Heron Therapeutics, Inc. /De/ annual Operating Lease, Payments for 2022 was $2.9M.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2020 $3.3M $1M +$200K +25% Jul 1, 2020 Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $3.1M $1M -$100K -9.09% Apr 1, 2020 Jun 30, 2020 10-Q 2020-08-05
Q1 2020 $3.2M $800K -$200K -20% Jan 1, 2020 Mar 31, 2020 10-Q 2020-05-06
Q4 2019 $3.4M $500K Oct 1, 2019 Dec 31, 2019 10-K 2020-03-02
Q3 2019 $800K Jul 1, 2019 Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $1.1M Apr 1, 2019 Jun 30, 2019 10-Q 2019-08-05
Q1 2019 $1M Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.